Digital Therapeutic Based Randomized Investigation to Improve Glycemic Control in Patients With Type 2 Diabetes and Residual Hyperglycemia on Stable Medical Therapy: Rationale, Design, and Baseline Characteristics of the BRIGHT Trial

Background The prevalence of type 2 diabetes continues to rise in the United States and worldwide. Although novel pharmacotherapies have shown benefits, not all patients have access to these medications and of those who do, some are unable to tolerate treatment. Behavior change is long known to be f...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής

Κύριοι συγγραφείς:	Mario Enrico Canonico, Judith Hsia, Frederick A. Masoudi, Hayden B. Bosworth, Stacy Greene, Bryan C. Batch, Natia Hamilton, Thiago B. de Araujo, Matthew Jackson, Marsha Broussard, Zonda Gooden, Nicole L. Guthrie, Bjorn Hansell, Laura Matteliano‐Madu, Kara Mosesso, Mark A. Berman, Marc P. Bonaca
Μορφή:	Artigo
Γλώσσα:	Inglês
Έκδοση:	Wiley 2025-08-01
Σειρά:	Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Θέματα:	AspyreRx BT‐001 digital therapeutics lifestyle management type 2 diabetes
Διαθέσιμο Online:	https://www.ahajournals.org/doi/10.1161/JAHA.124.038737
Ετικέτες:	Προσθήκη ετικέτας Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!